Methodological mimesis and the value of pharmaceutical failures
Recent controversies over the safety of drugs such as Vioxx, a painkiller manufactured by Merck, and Seroxat, an SSRI antidepressant manufactured by GlaxoSmithKline, have led to a consequence that at first seems entirely positive: they have attracted more attention to the suppression of negative cli...
| 第一著者: | |
|---|---|
| フォーマット: | Conference item |
| 出版事項: |
2009
|